Mirae Asset Global Investments’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29,234
Closed -$134K 2586
2023
Q3
$134K Hold
29,234
﹤0.01% 2402
2023
Q2
$327K Buy
+29,234
New +$311K ﹤0.01% 2145
2022
Q2
Sell
-21,184
Closed -$210K 2434
2022
Q1
$210K Sell
21,184
-30,000
-59% -$296K ﹤0.01% 1535
2021
Q4
$507K Buy
51,184
+10,000
+24% +$98.9K ﹤0.01% 1442
2021
Q3
$404K Buy
+41,184
New +$406K ﹤0.01% 1535

Other funds holding PROK

Mirae Asset Global Investments's PROK Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of ProKidney (PROK) in Q4 2023, closing a stake of 29,234 shares — an estimated $134K sold.

Mirae Asset Global Investments first reported a position in PROK in Q3 2021 and held it in 5 quarters. The position peaked at $507K in Q4 2021. 61 funds tracked by Wall St. Rank hold PROK as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining ProKidney position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 29,234 ProKidney shares in Q4 2023, an estimated $134K.
  • Mirae Asset Global Investments first reported a position in ProKidney in Q3 2021 and held it in 5 quarters.
  • Mirae Asset Global Investments's ProKidney position peaked at $507K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held ProKidney as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.